Clinical Trial
[Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences]
[Article in
German]
- PMID: 812129
Item in Clipboard
Clinical Trial
[Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences]
[Article in
German]
Psychiatr Neurol Med Psychol (Leipz).
1975 Feb.
Abstract
The clinical trials of Di-n-propylacetate (Depakine, Labaz) produced favorable results with 15 patients, whose epilepsies were characterized by exceptional therapy-resistant absences, partly in combination with grand mal (4 patients). After discontinuation of DPA and renewed application of this drug at a later stage the patients made a good recovery.
Similar articles
-
[The treatment of primary generalized epilepsies with dipropyl acetate (DPA)].Fortschr Med. 1977 Apr 7;95(13):892-6. Fortschr Med. 1977. PMID: 403114 German.
-
[Treatment of epilepsy in children using dipropyl acetic acid (DPA)].Fortschr Med. 1973 May 10;91(13):590-1 passim. Fortschr Med. 1973. PMID: 4633749 German. No abstract available.
-
[Sodium salt of n-dipropylacetic acid or Depakin in the therapy of epilepsy. Preliminary note].Riv Neurol. 1972 Sep-Oct;42(5):452-8. Riv Neurol. 1972. PMID: 4631199 Clinical Trial. Italian. No abstract available.
-
Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review.Epilepsia. 1975 Nov;16(4):549-73. doi: 10.1111/j.1528-1157.1975.tb04738.x. Epilepsia. 1975. PMID: 812693 Review.
-
[Treatment of epilepsy].Duodecim. 1974;90(21):1414-48. Duodecim. 1974. PMID: 4217271 Review. Finnish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials